Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals. 1991

R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
Department of Immunology, University of Göttingen, Germany.

Two sensitive sandwich ELISAs based on monoclonal antibodies directed to native C6 and C7 allowed the detection and quantitation of these complement proteins in 20 out of 37 serum samples from individuals who had previously been classified as deficient in these proteins as assessed by immunochemical and/or functional assays. Furthermore, serum from four C6-deficient and one combined C6-/C7-deficient individual showed an increase in the terminal complement complex (TCC) and a decrease in native C6 and C7 after complement activation as assayed by specific ELISAs. Despite their (incomplete) deficiencies, these individuals therefore possess functionally active terminal complement proteins with respect to their ability to generate the TCC. As these individuals have no history of a susceptibility to neisserial infections, even low concentrations of functionally active C6 and C7 may provide sufficient protection against those micro-organisms whose destruction requires TCC formation.

UI MeSH Term Description Entries
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003183 Complement C6 A 105-kDa serum glycoprotein with significant homology to the other late complement components, C7-C9. It is a polypeptide chain cross-linked by 32 disulfide bonds. C6 is the next complement component to bind to the membrane-bound COMPLEMENT C5B in the assembly of MEMBRANE ATTACK COMPLEX. It is encoded by gene C6. C6 Complement,Complement 6,Complement Component 6,C6, Complement,Complement, C6,Component 6, Complement
D003184 Complement C7 A 93-kDa serum glycoprotein encoded by C7 gene. It is a polypeptide chain with 28 disulfide bridges. In the formation of MEMBRANE ATTACK COMPLEX; C7 is the next component to bind the C5b-6 complex forming a trimolecular complex C5b-7 which is lipophilic, resembles an integral membrane protein, and serves as an anchor for the late complement components, C8 and C9. C7 Complement,Complement 7,Complement Component 7,C7, Complement,Complement, C7,Component 7, Complement
D003186 Complement C9 A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 (mC9) binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 (MEMBRANE ATTACK COMPLEX) and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections. C9 Complement,Complement 9,Complement Component 9,C9, Complement,Complement, C9,Component 9, Complement
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings

Related Publications

R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
June 1987, Scandinavian journal of immunology,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
June 1995, Kidney international,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
January 1979, Journal of immunological methods,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
November 1982, Molecular immunology,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
April 1995, Annals of human genetics,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
September 1979, Journal of immunology (Baltimore, Md. : 1950),
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
September 1988, Jinrui idengaku zasshi. The Japanese journal of human genetics,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
November 2021, Proteomics,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
January 1989, Human heredity,
R Würzner, and A Orren, and P Potter, and B P Morgan, and D Ponard, and P Späth, and M Brai, and M Schulze, and L Happe, and O Götze
March 2003, Legal medicine (Tokyo, Japan),
Copied contents to your clipboard!